Group One Trading’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,900
| Closed | -$18K | – | 9199 |
|
|
2021
Q3 | $18K | Buy |
2,900
+2,000
| +222% | +$12.5K | ﹤0.01% | 7250 |
|
|
2021
Q2 | $7K | Buy |
900
+700
| +350% | +$5.95K | ﹤0.01% | 7681 |
|
|
2021
Q1 | $2K | Sell |
200
-1,000
| -83% | -$11.5K | ﹤0.01% | 7430 |
|
|
2020
Q4 | $14K | Hold |
1,200
| – | – | ﹤0.01% | 5682 |
|
|
2020
Q3 | $12K | Buy |
1,200
+800
| +200% | +$9.8K | ﹤0.01% | 5366 |
|
|
2020
Q2 | $5K | Sell |
400
-1,900
| -83% | -$19.7K | ﹤0.01% | 5394 |
|
|
2020
Q1 | $18K | Sell |
2,300
-9,100
| -80% | -$137K | ﹤0.01% | 4297 |
|
|
2019
Q4 | $236K | Buy |
11,400
+7,400
| +185% | +$125K | ﹤0.01% | 3055 |
|
|
2019
Q3 | $55K | Buy |
4,000
+2,600
| +186% | +$30.9K | ﹤0.01% | 3937 |
|
|
2019
Q2 | $17K | Buy |
+1,400
| New | +$16.2K | ﹤0.01% | 4248 |
|
|
2019
Q1 | – | Sell |
-17,500
| Closed | -$198K | – | 5593 |
|
|
2018
Q4 | $198K | Buy |
17,500
+13,000
| +289% | +$204K | ﹤0.01% | 2695 |
|
|
2018
Q3 | $84K | Sell |
4,500
-2,400
| -35% | -$55.1K | ﹤0.01% | 3645 |
|
|
2018
Q2 | $178K | Sell |
6,900
-6,000
| -47% | -$156K | ﹤0.01% | 3144 |
|
|
2018
Q1 | $289K | Buy |
12,900
+5,400
| +72% | +$132K | ﹤0.01% | 2502 |
|
|
2017
Q4 | $188K | Sell |
7,500
-7,300
| -49% | -$179K | ﹤0.01% | 2960 |
|
|
2017
Q3 | $358K | Buy |
14,800
+3,100
| +26% | +$72.9K | ﹤0.01% | 2340 |
|
|
2017
Q2 | $237K | Buy |
11,700
+9,200
| +368% | +$192K | ﹤0.01% | 2524 |
|
|
2017
Q1 | $67K | Buy |
+2,500
| New | +$51K | ﹤0.01% | 3227 |
|
|
2016
Q4 | – | Sell |
-200
| Closed | -$4K | – | 5001 |
|
|
2016
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 4273 |
|
|
2016
Q2 | $3K | Buy |
+200
| New | +$2.51K | ﹤0.01% | 4394 |
|
|
2016
Q1 | – | Sell |
-400
| Closed | -$8K | – | 5132 |
|
|
2015
Q4 | $8K | Buy |
400
+100
| +33% | +$1.74K | ﹤0.01% | 4268 |
|
|
2015
Q3 | $4K | Buy |
+300
| New | +$7.04K | ﹤0.01% | 4576 |
|
Group One Trading's FLXN Position: Q4 2021 in Review
Group One Trading sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 10,833 shares — an estimated $66K sold.
Group One Trading first reported a position in FLXN in Q3 2015 and held it in 14 quarters. The position peaked at $227K in Q1 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Group One Trading reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 10,833 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $66K.
- Group One Trading first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 14 quarters.
- Group One Trading's Flexion Therapeutics, Inc. position peaked at $227K in Q1 2018.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.